Sook Hee Hong

Professor

Catholic University of Korea Eunpyeong St Mary's Hospital

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Immunology Immunology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Sook Hee Hong is a faculty member at Seoul St. Mary's Hospital, Catholic University of Korea, South Korea. Her research focuses on oncology, particularly in areas such as the prognostic value of various biomarkers in cancer and the implications of anesthesia on oncological outcomes. Recent publications include studies on skeletal muscle density in cancer patients, risk stratification in endometrial cancer, and the effects of immunotherapy in non-small cell lung cancer.

Articles (11)

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Se Jun Park

The Catholic University of Korea

SOUTH KOREA

View details

MyungAh Lee

The Catholic University of Korea

SOUTH KOREA

View details

Sung Jong Lee

The Catholic University of Korea

SOUTH KOREA

View details

JIN YOUNG CHON

Professor

Catholic University of Korea School of Medicine

SOUTH KOREA

View details

Tae-Min Kim

Professor

Catholic Kwandong University College of Medicine

SOUTH KOREA

View details

Soon Auck Hong

Associate Professor

Chung Ang University Hospital

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sook Hee Hong

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Skeletal Muscle Density as a Predictor of Prognosis and Physical Reserve in Patients with Cancer of Unknown Primary

Effect of total intravenous versus inhalation anesthesia on long-term oncological outcomes in patients undergoing curative resection for early-stage non-small cell lung cancer: a retrospective cohort study

Enhanced Risk Stratification in Early-Stage Endometrial Cancer: Integrating POLE through Droplet Digital PCR and L1CAM

EGFR-Tyrosine Kinase Inhibitors Induced Activation of the Autocrine CXCL10/CXCR3 Pathway through Crosstalk between the Tumor and the Microenvironment in EGFR-Mutant Lung Cancer

Transcriptional Profiling Reveals Mesenchymal Subtypes of Small Cell Lung Cancer with Activation of the Epithelial-to-Mesenchymal Transition and Worse Clinical Outcomes

The Prognostic Value of Sex-Determining Region Y-Box 2 and CD8+ Tumor-Infiltrating Lymphocytes in Limited-Stage Small-Cell Lung Cancer.

The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy.

How to start niraparib in real-world Asian ovarian cancer patients?

Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07.

Prognostic effects of histology-based tumour microenvironment scores in resected distal bile duct cancer.

Evaluation of Two EGFR Mutation Tests on Tumor and Plasma from Patients with Non-Small Cell Lung Cancer.

Collaborators (6)

Se Jun Park

MyungAh Lee

Sung Jong Lee

JIN YOUNG CHON

Tae-Min Kim

Soon Auck Hong

Make your next move.